Latest News

Jefferies upgrades Tilray to buy, says pot stock can soar more than 60%


A security guard stands in a greenhouse of Tilray medical cannabis producer’s European production site in Cantanhede, on April 24, 2018.

Patricia De Melo Moreira | AFP | Getty Images

The merger between cannabis companies Aphria and Tilray officially closed this week, and the resulting company is set up to be a major player in multiple countries as legal weed gains steam, according to Jefferies.

Analyst Owen Bennett upgraded Tilray to buy from underperform on Friday, saying in a note to clients that the strengths of the two companies complement one another and position the new company for success in Europe and North America.

China’s trade with the U.S. and Australia grew in April despite tensions

Previous article

DraftKings raises full-year guidance, expecting a return in sports

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News